EXELIXIS

Swiss trademark · 715865 · Combined mark · In force

Register entry

Registration number
715865
Application number
50287/2018
Status
In force
Type
Combined mark
As registered
EXELIXIS ((fig.))
Filed
Jan 9, 2018
Registered
May 2, 2018
Published
May 2, 2018
Protected until
Jan 9, 2028
Priority
12.07.2017 US
Language of procedure
German
Vienna classes
04.05.03, 27.03.01, 27.03.02
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Behandlung von Krebs, Schmerzen, Infektionen, Entzündungen, Hormonstörungen, Knochenerkrankungen und psychischen Störungen; Analgetika; Hormone; Psychopharmaka; Präparate gegen Infektionserreger; entzündungshemmende Mittel; Präparate zur Krebsbekämpfung.

Science, technology and IT

Pharmaceutical research and development

As filed

Pharmazeutische Forschung und Entwicklung.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 14, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 14.12.2023

  2. Aug 13, 2019

    Holder’s address changed

    Owner
    Exelixis, Inc., 210 East Grand Avenue, South San Francisco, CA-94080, USA → Exelixis, Inc., 1851 Harbor Bay Parkway, Alameda, CA 94502, USA

    Published in Swissreg on 13.08.2019

  3. May 2, 2018

    Registered

    Published in Swissreg on 02.05.2018

Parties

Holder

Exelixis, Inc.

1851 Harbor Bay Parkway, Alameda, CA 94502, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.